Mirum Pharmaceuticals Balance Sheet
NASDAQ: MIRMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Mirum Pharmaceuticals financial position
At the end of fiscal 2025, Mirum Pharmaceuticals reported total assets of $842.8 million, up 25.7% from a year earlier against total liabilities of $528.1 million. Shareholders' equity stood at $314.7 million, or 37.3% of assets. The company held $296.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 2.67, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Mirum Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 296.68M | 222.50M | 286.33M | 28.00M | 31.34M | 142.09M | 11.97M |
| Short-Term Investments | 86.64M | 57.81M | 0 | 123.72M | 125.20M | 89.73M | 104.69M |
| Receivables | 123.33M | 78.29M | 67.97M | 23.99M | 3.27M | 0 | — |
| Inventory | 24.89M | 22.40M | 22.31M | 5.57M | 1.51M | 0 | — |
| Total Current Assets | 549.68M | 392.79M | 387.54M | 190.22M | 166.59M | 236.35M | 119.36M |
| Property, Plant & Equipment | 1.86M | 1.14M | 706.00K | 914.00K | 981.00K | 1.29M | 1.37M |
| Intangible Assets | 260.92M | 249.82M | 252.93M | 58.95M | 18.74M | 0 | — |
| Long-Term Investments | 8.11M | 12.53M | 0 | 0 | 4.98M | 0 | 23.29M |
| Total Assets | 842.81M | 670.75M | 646.62M | 352.91M | 294.65M | 240.86M | 146.71M |
| Accounts Payable | 9.61M | 14.62M | 7.42M | 8.69M | 9.17M | 3.15M | 3.35M |
| Total Current Liabilities | 205.80M | 126.55M | 87.06M | 64.73M | 42.60M | 18.46M | 13.08M |
| Total Liabilities | 528.12M | 445.11M | 397.95M | 210.87M | 174.44M | 68.77M | 16.36M |
| Shareholders' Equity | 314.69M | 225.64M | 248.67M | 142.04M | 120.21M | 172.09M | 130.35M |
| Retained Earnings | -667.54M | -644.18M | -556.24M | -392.82M | -257.16M | -173.17M | -69.90M |
| Net Cash (Debt) | 383.33M | 280.31M | 286.33M | 151.72M | 156.54M | 231.82M | 116.66M |
| Shares Outstanding | 51.90M | 48.34M | 46.72M | 36.96M | 30.58M | 29.78M | 22.60M |
This table shows 7 annual periods of Mirum Pharmaceuticals's balance sheet, from FY 2025 back to FY 2019, across 16 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow MIRM's reporting calendar. What is a balance sheet?